This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Pfizer Inc., a global pharmaceutical corporation headquartered in New York. The $443,481.61 delivery order contract is for firm fixed-price medical supplies and pharmaceuticals, including controlled substances, injectable medications, and critical medical products. The contract has no small business set-aside designation, reflecting Pfizer's status as a large, established manufacturer.
Pfizer holds two significant Indefinite Delivery Vehicle (IDV) contracts with the federal government. The first is a $46,893,140 IDV for Bevacizumab injections, serving multiple agencies including the Department of Veterans Affairs, Department of Defense, and Centers for Disease Control and Prevention. The second is a $2,007,801,000 IDV with the CDC for the Vaccines for Children (VFC) program, which will provide pediatric vaccines from April 2025 through March 2026. These IDVs demonstrate Pfizer's comprehensive capabilities in supplying complex pharmaceutical products across diverse government healthcare programs.